Executives On The Move: Sanofi Acquires Development Talent And Senior Leadership Exits At Biogen And Bristol-Myers Squibb
Executive Summary
French multinational pharma Sanofi taps cancer specialist for head of development and global rare disease firm CSL Behring hires former Biogen EVP as COO. At Gilead Sciences, a new chief commercial officer joins from Bristol-Myers Squibb.